Genetic Testing Market Size, Share & Trends Analysis, By Type (Predictive & Presymptomatic Testing, Carrier Testing), By Application (Cancer Diagnosis, Genetic Disease Diagnosis), By Product, By Technology, By Region and Forecast Period 2022 – 2030

Report ID - MRC_2196 | Pages - 201 | Category - Healthcare IT

Genetic Testing Market Insights:

Genetic Testing Market was valued at USD 930.34 Million in 2021 and is anticipated to grow at a CAGR of 12.99% and is expected to reach USD 2792.56 Million by 2030.

Genetic testing is a process that involves analyzing an individual’s DNA to identify variations or mutations in their genetic code that may indicate a predisposition to certain diseases or conditions. This type of testing can be used to diagnose genetic disorders, predict the risk of developing certain conditions, or to determine the likelihood of passing a genetic disorder on to future generations. Genetic testing can be performed on a variety of samples, including blood, saliva, or skin cells, and can be done at any stage of life.

How much is the Genetic Testing Market worth ?

img

Get Free Sample PDF

This growth is driven by factors such as the increasing prevalence of genetic disorders, the growing awareness of the benefits of genetic testing, and the advancement of technology that has made genetic testing more accessible and affordable. This market is a rapidly growing industry with a wide range of applications and technologies. The increasing prevalence of genetic disorders, the growing awareness of the benefits of genetic testing, and the advancement of technology are all driving factors for the growth of the market.

Market Dynamics:

Driver:

The genetic testing market is the increasing prevalence and awareness of genetic disorders and diseases. As the population ages, the number of people with genetic conditions is expected to rise, leading to a greater demand for genetic testing. Additionally, advancements in technology have made genetic testing more accessible and affordable, further driving market growth. The growing awareness of the importance of genetic testing for disease prevention and early detection is also driving market growth. This has led to an increased demand for genetic testing in primary care settings.

Restraints:

Genetic testing can be expensive which makes it difficult for some individuals to afford. This reduces the use of genetic testing services done by number of people. Also Insurance companies does not cover the cost of genetic testing. Only few people are aware about the use of genetic testing services which leads to low demand for the service. Some of the test may also provide false or inaccurate results.

Opportunities:

The rapid growth of the technology in this field of genetics has made it more accessible and affordable. New Generation Sequencing (NGS) has made it simpler to analyze more and larger amount of genetic data with accurate results. Genetic testing can be used to identify genetic variations that may influence an individual’s response to certain treatments. This tests help to identify individuals who are susceptible of specific diseases or conditions. Efforts to increase awareness and education about the benefits of genetic testing can help to increase demand for genetic testing services. Government support for genetic testing, such as funding for research and development, can help to accelerate the growth of the genetic testing market.

Covid-19 Impact:

The pandemic has had a significant impact on the testing market. The pandemic has led to a decrease in demand for genetic testing services as many individuals have been unable to access testing services due to lockdowns and social distancing measures. Additionally, many individuals have been unable to afford genetic testing services due to financial constraints caused by the pandemic. The pandemic has also led to some opportunities for the genetic testing market. The test has been used to identify genetic mutations that may be related to the development of severe COVID-19 cases. This has led to an increase in demand for genetic testing services related to COVID-19.

Genetic Testing Report Coverage:

Report AttributesReport Details
Study Timeline2016-2030
Market Size in 2030 (USD Billion)2792.56 Million
CAGR (2022-2030)12.99%
By TypePredictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Others
By Technology    Polymerase Chain Reaction (PCR), Next-generation sequencing (NGS), Fluorescence in situ hybridization (FISH)
By ApplicationCancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Others
By ProductConsumables, Equipment, Software, Services
By End UserHospitals, Clinical Labs
By GeographyNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
Key PlayersMyriad Genetics, Inc. (Myriad Rbm Inc.), Eurofins Scientific, Thermo Fisher Scientific, Inc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd, Illumina, Inc.

Get Free Sample PDF

Market Segmentation:

By Type

Type Segment is divided into Predictive & Presymptomatic Testing, Carrier Testing, Diagnostic Testing, Newborn Testing. Predictive is type of testing which is used to identify individuals who have a high risk of developing a genetic disorder in the future. It’s usually done when a person has a family history of a genetic disorder or when a genetic disorder is suspected based on other factors. Carrier testing are the type of testing used to identify individuals who carry genetic mutations that could potentially be passed on to their children. It’s usually done by individuals who are planning to have a child or are pregnant. Newborn screening testing is done on newborns to detect certain genetic disorders or conditions that can be treated early on. While as prenatal testing is done to identify genetic disorders in unborn children. It’s usually done during the first or second trimesters of pregnancy. Diagnostic testing helps to identify genetic disorders in individuals who have symptoms of a specific condition. Pharmacogenetic testing identifies genetic variations that may influence an individual’s response to certain medications.

By Technology

PCR is a widely used technology that amplifies small segments of DNA. It’s used to detect the presence of specific genetic mutations or variations. NGS is a newer technology that can analyze large amounts of genetic data quickly and accurately. It’s used to identify genetic variations that may be related to the development of certain diseases or conditions. Hybridization-based methods are used to detect genetic variations by analyzing the binding of probes to specific regions of DNA. These are the main technologies used in genetic testing, each technology has its own advantages and disadvantages, and each technology is used for a specific purpose.

By Application

Cardiology testing is used in cardiology to identify genetic mutations that may be related to the development of heart disease. This helps to identify individuals who are at high risk of developing heart disease and inform treatment decisions. Treatment decisions, monitor treatment response, identify new treatment options, and identify recurrence and hereditary cancer. As genetic testing technologies continue to advance, the use of genetic testing in cancer diagnosis and management is expected to become increasingly widespread. Genetic testing can help to improve outcomes for cancer patients by providing more accurate and personalized treatment options.

By Product

The testing services include the analysis and interpretation of test results. They are provided by clinical laboratories, hospitals, or genetic testing companies. These services can include genetic counseling, which is essential for individuals who are considering genetic testing or who have received genetic test results. Software is used to analyze genetic test results and to interpret the data. It can be used to identify genetic variations to predict the risk of developing certain diseases or conditions, or to monitor the response of cancer cells to treatment.

By End User

Testing are often performed in hospitals and clinics. These facilities typically provide genetic testing services to patients who have been referred by a healthcare provider. Clinical laboratories use various genetic testing technologies, such as PCR, NGS, and microarray, to perform a wide range of genetic tests.

By Region

The regional segment includes North America, Europe, Asia Pacific, the Middle East, and Africa, Latin America. Each region has its own specific regulations, cultural beliefs, and healthcare systems that affect the genetic testing market. The demand for genetic testing services is also affected by the level of economic development, healthcare infrastructure, and the availability of genetic testing services in each region. It is widely used in North America, especially in United States. Asia-Pacific and Latin America are the rapidly growing region in this field.

Genetic Testing Market Competitive Landscape:

The genetic testing market is a highly competitive landscape with a large number of companies offering a variety of genetic testing services. These companies offer a wide range of genetic testing services, including diagnostic testing, carrier testing, and prenatal testing. Additionally, there are many smaller companies and start-ups that are also competing in the market with specialized or niche testing services. Overall, the market is expected to continue to grow due to increasing demand for genetic testing and advancements in technology. Some of the major players in the market include-

  • Myriad Genetics, Inc. (Myriad Rbm Inc.)
  • Eurofins Scientific
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation (Cepheid)
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.

Genetic Testing Market Recent Developments:

  • Non-invasive prenatal testing (NIPT) is a test that uses a blood sample from the mother to analyze fetal DNA and is used to screen for chromosomal abnormalities such as Down syndrome. This method is less invasive than traditional prenatal testing methods, such as amniocentesis, and can be performed earlier in pregnancy.
  • NGS technology has greatly expanded the range of genetic testing that can be performed, making it possible to analyze entire genomes and exomes in a single test. This has led to the development of more comprehensive genetic testing panels, which can detect a wider range of genetic conditions.

Table of Content

To check our Table of Contents, please mail us at: [email protected]

Research Methodology

The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.

Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.

Genetic Testing Market Size, Share & Trends Analysis, By Type (Predictive & Presymptomatic Testing, Carrier Testing), By Application (Cancer Diagnosis, Genetic Disease Diagnosis), By Product, By Technology, By Region and Forecast Period 2022 – 2030
Back to top button